Home › Funds › Millennium Management › GLMD
Millennium Management position in GLMD
GALMED PHARMACEUTICALS LTD
Latest position (Q3 2023)20.13K sh
Reported value held$12.48K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 13.04K | $36.00K | New |
| Q4 2021 | 53.24K | $97.00K | Add |
| Q1 2022 | 10.74K | $17.00K | Reduce |
| Q2 2022 | 50.75K | $35.00K | Add |
| Q3 2022 | 46.87K | $15.00K | Reduce |
| Q4 2022 | 149.22K | $75 | Add |
| Q1 2023 | 131.63K | $56 | Reduce |
| Q2 2023 | 14.91K | $43.38K | Reduce |
| Q3 2023 | 20.13K | $12.48K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GLMD
- Citadel Advisors 86.85K sh · $48.31K · Q2 2026
- Morgan Stanley 56 sh · $31 · Q2 2026
- Wells Fargo & Co 43 sh · $24 · Q2 2026
- UBS Group AG 3 sh · $2 · Q2 2026